High-Dose Therapy and Stem-Cell Rescue for Ewing's Family of Tumors in Second Remission
Author:
Affiliation:
1. Stanford University School of Medicine, Palo Alto, CA
2. Memorial Sloan-Kettering Cancer Center, New York, NY
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.12.915
Reference20 articles.
1. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone
2. Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group Study
3. High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis
4. Survival after recurrence of Ewing Tumors
5. Survival After Recurrence of Ewing’s Sarcoma Family of Tumors
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sarcomas of Bone;Abeloff's Clinical Oncology;2020
2. Prognostic factors for survival in Ewing sarcoma: A systematic review;Surgical Oncology;2018-12
3. Investigational therapies for Ewing sarcoma: a search without a clear finding;Expert Opinion on Investigational Drugs;2016-04-07
4. Non-surgical Treatment of Pediatric Bone Sarcomas;Cañadell's Pediatric Bone Sarcomas;2015-12-01
5. Sarcomas of Bone;Abeloff's Clinical Oncology;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3